Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Neurodegenerative Disease > Chinese Markets for Alzheimer Disease Drugs
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Chinese Markets for Alzheimer Disease Drugs

Published by Asia Market Information & Development
Published April, 2009 Product code 86316
Content info 199 Pages
Price
US $ 4000 PDF by E-mail (Single User License)
US $ 8000 PDF by E-mail (Corporate Use License)


Chinese Markets for Alzheimer Disease Drugs published by Asia Market Information & Development in April, 2009. This report consists of 199 Pages and the price starts from US $ 4000.

Introduction

Abstract

China' s demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Table of Contents

I.INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II.BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III.ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer' s Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer' s Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Alzheimer' s Disease Drugs by Region
  • Alzheimer' s Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer' s Disease Drugs
  • Alzheimer' s Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer' s Disease Drugs Imports
  • Pricing Trend

V. ALZHEIMER' S DISEASE DRUGS MARKET OUTLOOK

  • Alzheimer' s Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China' s Distribution System
  • Alzheimer' s Disease Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China' s Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. ALZHEIMER' S DISEASE DRUGS PRODUCER DIRECTORY

  • Major Alzheimer' s Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer' s Disease Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Alzheimer' s Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Alzheimer' s Disease Drugs Sales Volume
  • Alzheimer' s Disease Drugs Major Producer and Their Market Share
  • Ginkgo Bilota Extract Major Producer and Their Market Share
  • Breviscapine Major Producer and Their Market Share
  • Ganglioside Major Producer and Their Market Share
  • Donepezil Major Producer and Their Market Share
  • Galanthamine Major Producer and Their Market Share
  • Dihydroergotamine Major Producer and Their Market Share
  • Rivastigmine Major Producer and Their Market Share
  • Memantine Major Producer and Their Market Share
  • Huperzine A Major Producer and Their Market Share
  • Oxiracetam Major Producer and Their Market Share
  • Flunarizine Major Producer and Their Market Share
  • Piracetam Major Producer and Their Market Share
  • Alzheimer' s Disease Drugs Import

V. ALZHEIMER' S DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. NTRODUCTION

  • Alzheimer' s Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China' s GDP and Industrial Output
  • Industrial Output by Ownership
  • China' s Imports and Exports

III. ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer' s Disease Drugs Sales Volume

IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND

  • Alzheimer' s Disease Drugs Sales Volume
  • Worldwide Alzheimer' s Disease Drugs Demand by Region
  • Ginkgo Bilota Extract Sales Volume and Market Share
  • Breviscapine Sales Volume and Market Share
  • Ganglioside Sales Volume and Market Share
  • Donepezil Sales Volume and Market Share
  • Galanthamine Sales Volume and Market Share
  • Dihydroergotamine Sales Volume and Market Share
  • Rivastigmine Sales Volume and Market Share
  • Memantine Sales Volume and Market Share
  • Huperzine A Sales Volume and Market Share
  • Oxiracetam Sales Volume and Market Share
  • Flunarizine Sales Volume and Market Share
  • Piracetam Sales Volume and Market Share
  • Other Alzheimer' s Disease Drugs Sales volume and market share
  • Alzheimer' s Disease Drugs Import Volume
  • Ginkgo Bilota Extract Import Volume and Market Share
  • Breviscapine Import Volume and Market Share
  • Ganglioside Import Volume and Market Share
  • Donepezil Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Dihydroergotamine Import Volume and Market Share
  • Rivastigmine Import Volume and Market Share
  • Memantine Import Volume and Market Share
  • Huperzine A Import Volume and Market Share
  • Oxiracetam Import Volume and Market Share
  • Flunarizine Import Volume and Market Share
  • Piracetam Import Volume and Market Share
  • Other Alzheimer' s Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China' s Distribution Channel
Back to Top